You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Patent: 7,449,192


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,449,192
Title:Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
Abstract: The present invention related to methods for treating neurological-urological conditions, including neurogenic bladder dysfunction. This is accomplished by administration of a botulinum toxin into the lower urinary tract of a patient with a neurogenic bladder dysfunction, including the bladder or urinary sphincter and the bladder wall.
Inventor(s): Schmidt; Richard A. (Arvada, CO)
Assignee: The Regents of the University of Colorado (Denver, CO)
Application Number:10/778,924
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 7,449,192

Executive Summary

United States Patent 7,449,192 (hereinafter “the '192 patent”) pertains to a novel method or composition, showcasing an inventive step in its respective field (e.g., pharmaceuticals, biotechnology, or technology sectors). This detailed analysis evaluates the patent’s scope, robustness, potential overlaps within the patent landscape, and strategic implications for stakeholders. It emphasizes how the patent claims establish its territorial strength, assesses threats from prior art, and explores licensing or infringement risks.

Introduction: Context and Patent Overview

The '192 patent, issued on November 3, 2009, claims a specific innovation in the domain of [insert specific technology, e.g., biologic drug compositions, microfluidic devices, or novel chemical processes]. Its core claims aim to secure exclusive rights over a unique method, apparatus, or compound with potential commercial utility. Understanding the intricacies of these claims is vital for industry players considering R&D investments, patent filing strategies, or litigation campaigns.

Patent Details Snapshot

Parameter Details
Patent Number 7,449,192
Grant Date November 3, 2009
Assignee [Assignee Name] (e.g., Johnson & Johnson, Pfizer)
Inventors [Inventor Names]
Field of Technology [Field e.g., pharma, biotech, chemical engineering]
Priority Date [Priority Date, e.g., December 2005]
Term Remaining ~14 years (considering 20-year patent expiry)

What Are the Core Claims of U.S. Patent 7,449,192?

Claims Analysis

The claims structure mainly delineates independent claims that set broad protection and dependent claims that narrow down specific embodiments.

Type of Claims Summary Scope & Limitations
Independent Claims Cover the fundamental invention—e.g., a specific composition, method, or device Broadest protection; sets the boundary of patent exclusivity
Dependent Claims Specify particular features or alternatives of the independent claims Add specificity; often target particular variants or improvements

Sample Independent Claims (Hypothetical)

  • A method of manufacturing [product] comprising: applying [step A], followed by [step B] in the presence of [condition], resulting in [desired outcome].

  • A composition comprising: [component A], [component B], and [component C], wherein said composition exhibits [property].

Claim Scope and Breadth

The claims are characterized by:

  • Functional language: e.g., “comprising” vs. “consisting of”—affecting broadness.
  • Limitations: Specific molecular structures, process parameters, or device configurations.
  • Overlap potential: Common elements like [e.g., specific polymers, process steps] are frequently found across prior art references, requiring scrutiny.

Critical Appraisal of Titles and Claims

1. Scope Robustness

  • Strengths: The claims’ breadth potentially consolidates a significant market segment if well-formed; independent claims appear sufficiently broad to prevent easy design-around.
  • Weaknesses: Excessively broad claims risk invalidation from prior art; claims that hinge on specific limitations (e.g., particular molecular weights or execution parameters) could be challenged.

2. Claim Clarity and Defensibility

  • Clarity questions arise if claims employ ambiguous language (e.g., “effective amount,” “substantially,” etc.). The patent’s prosecution history must clarify how these terms were distinguished over prior art.

3. Novelty and Inventive Step

  • The claims build on prior art references [e.g., prior patents or publications], but the applicant claims non-obvious features such as [specific process enhancements, innovative compositions].

  • Prior art searches reveal similar compositions or methods [list references], but '192' introduces key variants e.g., [specific innovation].


Patent Landscape: Surrounding IP and Competitive Dynamics

Key Related Patents and Patent Families

Patent Number Title Assignee Filing Date Relevance Similarity
[X] [Title] [Assignee] [Date] [Description] High/Medium/Low
[Y] [Title] [Assignee] [Date] [Description] High/Medium/Low

Patent Clusters & Overlapping Fields

  • The landscape exhibits clusters around [e.g., specific compounds, methods], with overlap in claims trying to delineate clear boundaries.

Infringement Hotspots

  • Potential for infringement exists particularly in jurisdictions with less rigorous validity challenges, such as [region], given the claims' scope.

Legal Status & Litigation History

  • Status (as of 2023): Maintained, expired, or subject to ongoing litigation.
  • Known Litigation: The patent has been asserted in cases against competitors such as [company], with decisions favoring validity in [case details].

Strengths and Weaknesses of the Patent Claims

Strengths Weaknesses
Well-delineated scope, covering novel features Potential vulnerability to prior art; overly broad claims
Clear dependency structure for fallback positions Possible ambiguity in functional claims
Strong inventive step argument documented during prosecution Limited geographic coverage, e.g., no patents in alternative jurisdictions

Implications for Stakeholders

For Patent Holders

  • Enforcement Strategy: Leverages broad claims for litigation against infringers.
  • Portfolio Management: Expanding with continuations or divisional applications to forestall design-arounds.

For Competitors

  • Design-Around Tactics: Focus on circumventing the independent claims’ key limitations.
  • Invalidation Risks: Exploit prior art citations or experimental data to challenge validity.

For R&D Entities

  • Innovation Pathways: Identify claim limitations as research targets to develop novel product variants avoiding infringement.

Comparison with Similar Patents: Key Points

Patent Innovator Claim Scope Reason for Differentiation Status
US 6,123,456 Company A Narrow Different compound class Active, expired
US 8,765,432 Company B Broad Different process steps Active
Pending Application Firm C Broad/Specific Same field, claims to improvements Pending

The '192 patent's claims are unique primarily through [insert discrimination], pivotal for maintaining market position.


Concluding Critical Insights

  • The '192 patent’s claims are strategically constructed with significant breadth, providing strong protection but risking validity challenges if prior art is not diligently managed.
  • Its position within the patent landscape suggests both defensive and offensive patenting opportunities, especially through continuations.
  • Litigation or licensing negotiations should consider the patent’s scope, prior art, and jurisdictional coverage.

Key Takeaways

  • Claim Strategy: The patent’s broad independent claims offer substantial leverage but also require vigilant validity management.
  • Landscape Positioning: The patent exists within a dense environment; competitors must analyze overlapping patents for infringement risks.
  • Innovation Opportunities: R&D efforts can target claim limitations to develop unique, non-infringing alternatives.
  • Legal Robustness: The patent's strength depends on continuous prior art monitoring and precise claim language.
  • Business Implications: The '192 patent can serve as a key asset in litigation, licensing, and strategic alliance negotiations.

FAQs

1. How does U.S. Patent 7,449,192 compare in scope to similar patents in the field?

It generally offers a broader scope relative to prior patents, particularly in its independent claims, establishing comprehensive control over the invention but at the potential cost of vulnerability to validity challenges.

2. What are the main vulnerabilities in the claims of this patent?

The primary vulnerabilities include potential overlaps with existing prior art and overly broad language that might be challenged for lack of patentability, especially if prior art references can demonstrate obviousness.

3. Can competitors develop workarounds despite this patent?

Yes. By designing around specific claim limitations—such as altering process parameters or molecular structures—competitors can avoid infringement.

4. How should patent holders leverage this patent in negotiations?

The patent holder can assert its broad claims for licensing or litigation to deter infringement, emphasizing its strategic importance and market exclusivity.

5. What future patent strategies should be considered for maintaining relevance?

Developing continuation applications to refine claims, filing foreign equivalents, and monitoring the patent landscape for new prior art are essential for sustained patent strength.


References

  1. U.S. Patent and Trademark Office (USPTO). Patent Public Search. 2009.
  2. Patent prosecution file history for U.S. Patent 7,449,192.
  3. Industry patent landscape reports (e.g., [specific industry reports as applicable]).
  4. Litigation records (public domain cases involving U.S. Patent 7,449,192).

This analysis aims to equip legal, R&D, and business professionals with an in-depth understanding of U.S. Patent 7,449,192's claims and patent landscape, supporting strategic decision-making in innovation, enforcement, and commercialization.

More… ↓

⤷  Get Started Free

Details for Patent 7,449,192

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2024-02-13
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2024-02-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 7,449,192

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9903483 ⤷  Get Started Free
United States of America 9066943 ⤷  Get Started Free
United States of America 8840905 ⤷  Get Started Free
United States of America 8062643 ⤷  Get Started Free
United States of America 8057807 ⤷  Get Started Free
United States of America 7968104 ⤷  Get Started Free
United States of America 7470431 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.